News

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.
LAS VEGAS — In this video, Tarek S. Hassan, MD, professor of ophthalmology at Oakland University William Beaumont Hospital, discusses interesting data presented at Clinical Trials at the ...
Weight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...
Biotech 4DMT lays off 25% of workforce while accelerating phase 3 eye gene therapy timeline By James Waldron Jul 3, 2025 4:52am 4D Molecular Therapeutics Cell & Gene Therapy layoffs wet AMD ...
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and new therapeutic targets fueling cautious hope.
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.
HealthDay News — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study ...
TUESDAY, July 1, 2025 (HealthDay News) — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, ...
Eli Lilly and Company is conducting a clinical study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in ...